Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Nephrology
Disease Category: Systemic Lupus Erythematosus
Location: United States, CA
Clinical Trial Details
Research Study Summary
A 48 week clinical trial for patients diagnosed with severe to moderate Lupus
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study for the Efficacy and Safety of Four 12-Week treatment Cycles (48 weeks total) of Drug in Systemic Lupus Erythematosus Subjects with Moderate to Severe Disease.
Patient Inclusion Criteria:
- At least 18 years old
- Diagnosed with Lupus (Moderate to Severe)
Patient Exclusion Criteria:
- Certain medications- please call to find out if you pre-qualify
To Learn more
Both Male and Female
Date Last Changed:
July 19, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.